Built on the pillar of forward-thinking products rooted in nature’s innate healing power, LAMAV, Australia’s first and largest Certified Organic Skincare line, is Utilizing Advanced Formulas and scientifically proven potent new Bio-Actives to refresh, rejuvenate and restore balance to the skin.
LAMAV Organic Skin Science combines the healing properties found in nature’s finest ingredients with advancements in modern science to create truly effective organic skin products that are free from harsh chemicals. These high-performing nutrient-dense bio-actives are chosen to focus on specific concerns encouraging youthfulness and ultra-hydration. Powerful adaptogenic herbs and nutrients, as well as potent Australian native botanical extracts, and essential oils combine to ensure every formula delivers results at a cellular level.
RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map
ACCESSWIRE
11 May 2021, 20:05 GMT+10
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.
(1)
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.
The project commenced in 2017, is designed to deliver a gene and protein expression map of healthy hair follicle cells expected to be critically important to improving key components of the manufacturing, regulatory, and clinical profile of RepliCel s cell therapy products.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium .
Arch Therapeutics, Inc.May 10, 2021 GMT
FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents two clinical case reports supporting the broad potential of AC5
® Advanced Wound System in chronic and non-healing wounds at the 2021 Symposium on Advanced Wound Care (SAWC) Spring this week. Both abstracts are available as Poster Presentations, and one abstract qualified for Podium Presentation in the Rapid Fire Symposium and earned a ribbon designation in the Poster Hall as the 2021 Highest Scoring Poster Abstract in the “Case Series/Study” category.